Clinical trial
Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related…
NCT00421018 · Karolinska Institutet, Other · Completed
Key facts
| NCT number | NCT00421018 |
|---|---|
| Title | Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK) |
| Official title | Optimization of the Anti-Inflammatory Treatment of Asthma Patients Through Exhaled NO Measurements for Increased Asthma-Related Quality of Life in Primary Health Care (NOAK) |
| Lead sponsor | Karolinska Institutet, Other |
| Collaborators | Region Stockholm Aerocrine AB Industry Phadia AB Meda AB The Swedish Research Council Swedish Council for Working Life and Social Research Merck Sharp & Dohme LLC Uppsala University |
| Status | Completed |
| Study type | Interventional |
| Conditions | Allergic Asthma |
| Intervention type | Drug |
| Interventions | Single corticosteroid inhalers and Singulair |
| Enrollment | 187 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Jan 11, 2007 |
| Last update posted | Aug 15, 2012 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: